Loïc Vincent, PhD, is Chief Scientific Officer at Affini-T Therapeutics, an independent director of the Board of Directors at Alaya.bio, and a member of the Scientific Advisory Board at General Inception. He is an oncology scientist with more than 20 years of international experience in the academia/biotech/pharma industry, dedicated to advancing transformative therapies to patients suffering from cancer. Previously, Loïc was the Head of Takeda Oncology Drug Discovery Unit and Immunology Unit, responsible for building the Immuno-Oncology portfolio with a global network of outstanding biotech and academic collaborators, and for leading Takeda Cell Therapy Discovery. During his career, Loïc’s teams advanced more than 20 oncology drugs in the clinic based on various therapeutic modalities including small molecules, biologics, oncolytic viruses and cell therapies. Loïc is the author and co-author of more than 30 peer-reviewed publications, and more than 80 poster and oral presentations.